Cargando…
The Role of Biological Rhythms in New Drug Formulations to Cross the Brain Barriers
For brain protection, the blood–brain barrier and blood–cerebrospinal fluid barrier limit the traffic of molecules between blood and brain tissue and between blood and cerebrospinal fluid, respectively. Besides their protective function, brain barriers also limit the passage of therapeutic drugs to...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454916/ https://www.ncbi.nlm.nih.gov/pubmed/37628722 http://dx.doi.org/10.3390/ijms241612541 |
_version_ | 1785096318761304064 |
---|---|
author | Mineiro, Rafael Albuquerque, Tânia Neves, Ana Raquel Santos, Cecília R. A. Costa, Diana Quintela, Telma |
author_facet | Mineiro, Rafael Albuquerque, Tânia Neves, Ana Raquel Santos, Cecília R. A. Costa, Diana Quintela, Telma |
author_sort | Mineiro, Rafael |
collection | PubMed |
description | For brain protection, the blood–brain barrier and blood–cerebrospinal fluid barrier limit the traffic of molecules between blood and brain tissue and between blood and cerebrospinal fluid, respectively. Besides their protective function, brain barriers also limit the passage of therapeutic drugs to the brain, which constitutes a great challenge for the development of therapeutic strategies for brain disorders. This problem has led to the emergence of novel strategies to treat neurological disorders, like the development of nanoformulations to deliver therapeutic agents to the brain. Recently, functional molecular clocks have been identified in the blood–brain barrier and in the blood–cerebrospinal fluid barrier. In fact, circadian rhythms in physiological functions related to drug disposition were also described in brain barriers. This opens the possibility for chronobiological approaches that aim to use time to improve drug efficacy and safety. The conjugation of nanoformulations with chronobiology for neurological disorders is still unexplored. Facing this, here, we reviewed the circadian rhythms in brain barriers, the nanoformulations studied to deliver drugs to the brain, and the nanoformulations with the potential to be conjugated with a chronobiological approach to therapeutic strategies for the brain. |
format | Online Article Text |
id | pubmed-10454916 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-104549162023-08-26 The Role of Biological Rhythms in New Drug Formulations to Cross the Brain Barriers Mineiro, Rafael Albuquerque, Tânia Neves, Ana Raquel Santos, Cecília R. A. Costa, Diana Quintela, Telma Int J Mol Sci Review For brain protection, the blood–brain barrier and blood–cerebrospinal fluid barrier limit the traffic of molecules between blood and brain tissue and between blood and cerebrospinal fluid, respectively. Besides their protective function, brain barriers also limit the passage of therapeutic drugs to the brain, which constitutes a great challenge for the development of therapeutic strategies for brain disorders. This problem has led to the emergence of novel strategies to treat neurological disorders, like the development of nanoformulations to deliver therapeutic agents to the brain. Recently, functional molecular clocks have been identified in the blood–brain barrier and in the blood–cerebrospinal fluid barrier. In fact, circadian rhythms in physiological functions related to drug disposition were also described in brain barriers. This opens the possibility for chronobiological approaches that aim to use time to improve drug efficacy and safety. The conjugation of nanoformulations with chronobiology for neurological disorders is still unexplored. Facing this, here, we reviewed the circadian rhythms in brain barriers, the nanoformulations studied to deliver drugs to the brain, and the nanoformulations with the potential to be conjugated with a chronobiological approach to therapeutic strategies for the brain. MDPI 2023-08-08 /pmc/articles/PMC10454916/ /pubmed/37628722 http://dx.doi.org/10.3390/ijms241612541 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Mineiro, Rafael Albuquerque, Tânia Neves, Ana Raquel Santos, Cecília R. A. Costa, Diana Quintela, Telma The Role of Biological Rhythms in New Drug Formulations to Cross the Brain Barriers |
title | The Role of Biological Rhythms in New Drug Formulations to Cross the Brain Barriers |
title_full | The Role of Biological Rhythms in New Drug Formulations to Cross the Brain Barriers |
title_fullStr | The Role of Biological Rhythms in New Drug Formulations to Cross the Brain Barriers |
title_full_unstemmed | The Role of Biological Rhythms in New Drug Formulations to Cross the Brain Barriers |
title_short | The Role of Biological Rhythms in New Drug Formulations to Cross the Brain Barriers |
title_sort | role of biological rhythms in new drug formulations to cross the brain barriers |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454916/ https://www.ncbi.nlm.nih.gov/pubmed/37628722 http://dx.doi.org/10.3390/ijms241612541 |
work_keys_str_mv | AT mineirorafael theroleofbiologicalrhythmsinnewdrugformulationstocrossthebrainbarriers AT albuquerquetania theroleofbiologicalrhythmsinnewdrugformulationstocrossthebrainbarriers AT nevesanaraquel theroleofbiologicalrhythmsinnewdrugformulationstocrossthebrainbarriers AT santosceciliara theroleofbiologicalrhythmsinnewdrugformulationstocrossthebrainbarriers AT costadiana theroleofbiologicalrhythmsinnewdrugformulationstocrossthebrainbarriers AT quintelatelma theroleofbiologicalrhythmsinnewdrugformulationstocrossthebrainbarriers AT mineirorafael roleofbiologicalrhythmsinnewdrugformulationstocrossthebrainbarriers AT albuquerquetania roleofbiologicalrhythmsinnewdrugformulationstocrossthebrainbarriers AT nevesanaraquel roleofbiologicalrhythmsinnewdrugformulationstocrossthebrainbarriers AT santosceciliara roleofbiologicalrhythmsinnewdrugformulationstocrossthebrainbarriers AT costadiana roleofbiologicalrhythmsinnewdrugformulationstocrossthebrainbarriers AT quintelatelma roleofbiologicalrhythmsinnewdrugformulationstocrossthebrainbarriers |